Champions Oncology, Inc. (CSBR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Champions Oncology, Inc. (CSBR)
Company Performance

Current Price

as of Oct 18, 2024

$4.42

P/E Ratio

N/A

Market Cap

$60.08M

Description

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Metrics

Overview

  • HQHackensack, NJ
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerCSBR
  • Price$4.42-0.45%

Trading Information

  • Market Cap$60.08M
  • Float44.02%
  • Average Daily Volume (1m)15,360
  • Average Daily Volume (3m)51,282
  • EPS-$0.25

Company

  • Revenue$51.65M
  • Rev Growth (1yr)11.94%
  • Net Income$1.31M
  • Gross Margin49.70%
  • EBITDA Margin14.70%
  • EBITDA$2.07M
  • EV$71.81M
  • EV/Revenue1.39
  • P/EN/A
  • P/S1.20
  • P/BN/A
Documents